The Portfolio · BriefAll articles →
Quarterly Results

CHEMBONDCH · CHEMBOND CHEMICALS LIMITED · NSE · Filed 16 Jul · 1 min read

Chembond Chemicals: Q1 FY27 consolidated profit and revenue rise year-on-year

The specialty-chemicals maker reported higher consolidated revenue and net profit for the quarter ended June 30, 2026 than a year earlier, on a limited-review basis.

What was filed

On July 16, 2026, Chembond Chemicals Limited (formerly Chembond Chemical Specialties Limited) told the NSE and BSE that its Board had approved the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. The results carry a limited review report from the statutory auditors, S H B A & CO LLP, whose conclusion was not modified. The board meeting ran from 5.05 pm to 5.22 pm.

The quarter in brief

On a consolidated basis, revenue and profit both rose against the June 2025 quarter, while coming in below the sequentially higher March 2026 quarter. The company operates as a single business segment — the manufacture of specialty chemicals — and the consolidated numbers fold in subsidiaries in water technologies, distribution and industrial hygiene, plus step-down foreign subsidiaries in Malaysia and Thailand.

The auditors noted the two foreign step-down subsidiaries were not separately reviewed; their figures were management-certified and, per the filing, not material to the Group. The standalone entity, distinct from the consolidated Group, showed a smaller revenue base and a marked improvement in period profit versus the June 2025 quarter.

A tax-structure note

The filing records that the Group has opted for the tax structure prescribed under Section 200 of the Income Tax Act, 2025, except for one subsidiary that continues under the existing structure; the standalone entity has opted into this structure for FY2026-27. This is a disclosure of the elected regime rather than a change to reported results beyond the tax lines shown.

Consolidated revenue from operations (Q1 FY26)
₹6,538.10 → ₹8,648.22 lakhQ1 FY26 → Q1 FY27+32%
Consolidated profit for the period (Q1 FY26)
₹627.01 → ₹954.99 lakhQ1 FY26 → Q1 FY27+52%
Consolidated basic EPS (Q1 FY26)
₹2.33 → ₹3.54Q1 FY26 → Q1 FY27+52%
Standalone profit for the period (Q1 FY26)
₹112.12 → ₹270.43 lakhQ1 FY26 → Q1 FY27+141%
Consolidated profit before tax (Q1 FY27)
₹1,278.32 lakh
Standalone revenue from operations (Q1 FY27)
₹1,843.73 lakh

‡ Computed by us from the filing’s own figures — not a company-stated number.

Quarterly results give holders a fresh read on the specialty-chemicals maker's operating trajectory and how its Group subsidiaries contribute; the figures are unaudited and subject to a limited review, not a full audit.

Share this

The brief

You just read one filing on CHEMBOND CHEMICALS. We do this every morning — for the stocks you own.

A calm, cited reading of your own holdings, delivered daily on Telegram or email. No tips.

Free during the pilot.

Read all articles